Fisher & Paykel Healthcare Corporation Limited (ASX:FPH)

Market Cap	19.90B +7.8%
Revenue (ttm)	1.89B +14.2%
Net Income	383.13M +144.8%
EPS	0.65 +144.1%
Shares Out	n/a
PE Ratio	51.95
Forward PE	46.67
Dividend	0.46 (1.37%)
Ex-Dividend Date	Dec 3, 2025

Volume	94,675
Average Volume	620,806
Open	34.10
Previous Close	33.83
Day's Range	33.97 - 34.44
52-Week Range	29.08 - 35.31
Beta	0.93
RSI	58.93
Earnings Date	Feb 27, 2026

About ASX:FPH

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company also offers adult respiratory products, including airvo system, optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilatio...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1934
• Employees: 7,440
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: FPH

Financial Performance

In fiscal year 2025, ASX:FPH's revenue was 2.02 billion, an increase of 15.96% compared to the previous year's 1.74 billion. Earnings were 377.20 million, an increase of 184.46%.

Financial numbers in NZD